癌-睾丸抗原与胶质瘤
摘要
目前对胶质瘤的传统治疗手段未能提高患者的生存率。免疫治疗作为一种辅助治疗手段具有一定的发展前景。寻找特异性的肿瘤抗原是开展肿瘤免疫治疗的前提。癌-睾丸抗原非常适用于肿瘤特异性免疫治疗。本文对癌-睾丸抗原在胶质瘤中表达规律、表达机理等作一综述,并对其应用于胶质瘤免疫治疗的前景作了展望。
出处
《国际神经病学神经外科学杂志》
2006年第2期187-190,共4页
Journal of International Neurology and Neurosurgery
基金
国家自然科学基金(No.30360026)
广西自然科学基金(桂科回No:0342011)
参考文献16
-
1Scanlar M J, Simpson A J, Old KI. The cancer/testis genes:Review, standardization, and commentary. Cancer Immun,2004,4(1) :1-15
-
2Chen YT, Venditti CA, Theiler G, et al. Identification of CT46/HORMAD l , an immunogenic cancer/testis antigen encoding a putative meiosis-related protein. Cancer Immun,2005,5:9-16
-
3Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer/Testis-Associated Genes : Identification, Expression Profile, and Putative Function, J Cell Physiol ,2003 , 194 ( 3 ) :272-288
-
4Liu G,Ying H,Zeng G,et al, HER-2, gpl00, and MAGE-1 Are Expressed in Human Glioblastoma and Recognized by Cytotoxic T Cells, Cancer Res ,2004,64 ( 14 ) :4980-4986
-
5Chi DD, Merchant RE, Rand R, Conrad A J, et al, Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas, Am J Pathol, 1997 , 150 ( 6 ) :2143-2152
-
6Scarcella DL, Chow CW, Conzales MF, et al. Expression of MAGE and GAGE in High-Grade Brain Tumors: A Potential Target for Specific Immunotherapy and Diagnostic Markers. Clin Cancer Res,1999,5(2) :335-341
-
7Sahin U, Koslowski M, Tureci O , et al. Expression of cancer testis genes in human brain tumors. Clin Cancer Res, 2000,6(10) :3916-3922
-
8Ayyouh M, Hesdorffer CS, Metthez G, et al. Identification of SSX-2 epitope presented by dendritic cells to circulating nutologous CD4^+ T cells. J Immunol,2004, 172 (11) :7206-7211
-
9Jager E, Gnjatic S, Nagata Y, et al, Induction of primary NY-ESO-1 immunity : CD8 + T lymphocyte and antibody responses in peptide- vaccinated patients with NY - ESO- 1 + cancer. Proc Natl Acad Sci U S A, 2000,97:12198-12203
-
10Chen YT, Scanlan MJ, Sahin U, et al. A testieular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA, 1997, 94 (5) :1914-1918
-
1方蕾.T细胞受体在肿瘤特异性免疫治疗中的作用[J].医学综述,1997,3(1):28-30.
-
2魏海明.癌基因蛋白抗原肽与肿瘤特异性免疫治疗[J].国外医学（免疫学分册）,1997,20(3):138-141. 被引量：3
-
3邹鸿志,郁宝铭.MAGE基因与肿瘤特异性免疫治疗[J].国外医学（肿瘤学分册）,2000,27(5):274-276. 被引量：2
-
4隋延仿.肿瘤特异性抗原研究与肿瘤特异性免疫治疗[J].陕西肿瘤医学,2001,9(1):1-2. 被引量：1
-
5张莉,王雪峰.喉癌患者树突状细胞体内诱导高效而特异的抗喉癌免疫[J].中国基层医药,2007,14(6):972-973. 被引量：1
-
6高江平,谷志远,李炎唐,郝好杰,李琦,赵亚力,邢占海.肾细胞癌尿激酶系统mRNA的表达[J].中华实验外科杂志,1998,15(4):322-323.
-
7陈晋峰,张力建,赵爱莲,王歈,吴楠,熊宏超,梁震,李吉友,黄信孚,杨跃.Thy-1肿瘤标记物在肺癌组织中的异常表达及其对肺癌患者预后的影响[J].中华医学杂志,2005,85(27):1921-1925. 被引量：7
-
8张积仁,张学庸,陈希陶,乔太东,陈宝军,樊代明.胃结肠肿瘤组织中MG5 MG9 MGd1 MGe1 MGb1单抗相应抗原的分布[J].单克隆抗体通讯,1990,6(4):32-34.
-
9张克强,毛宁,唐佩弦.肿瘤疫苗潜在的靶抗原——癌基因蛋白[J].国外医学（肿瘤学分册）,1999,26(1):4-7. 被引量：2
-
10张莉,王雪峰.子宫颈癌患者树突状细胞体内外诱导抗肿瘤免疫[J].中国全科医学,2008,11(1):21-23. 被引量：2
